DT-0111

N/A

Report date: 2024/12/19 11:40:22
NME

Base Information

Drug NameDT-0111
Drug Alias NameDT-0111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 3 antagonists
TargetsP2X purinoceptor 3
Therapy Area/IndicationsCoughPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDanmir Therapeutics LLCOrganix Inc
China Registration ClassN/A

Develop Information

Active CompaniesDanmir Therapeutics LLCOrganix Inc
Inactive CompaniesN/A
Active IndicationsCoughPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A